WASHINGTON -- (BUSINESS WIRE) -- The Association of Clinical Research Organizations (ACRO) today announced Executive Director Doug Peddicord, Ph.D. was named to the Board of Directors for the Clinical Data Interchange Standards Consortium (CDISC).
CDISC is a global non-profit organization that has established standards to support the acquisition, exchange, submission and archival of clinical research data and meta data. CDISC standards are vendor-neutral, platform-independent, and freely available via the CDISC website.
“The clinical research enterprise is data driven and ACRO members conduct approximately 50% of clinical trials globally. I am pleased to represent ACRO on the CDISC Board of Directors and offer the voice of the global CRO industry,” said Peddicord. “Establishing uniform data standards is an important step in optimizing the drug development process as we strive to make the process more efficient and less costly.”
Dr. Peddicord’s three-year term on the CDISC board begins January 1, 2013.
“We welcome Dr. Peddicord to the CDISC Board as CROs have been leaders in promoting the development and use of data standards to the benefit of research sponsors, regulators, investigators and patients,” said CDISC President Rebecca Kush.
The Association of Clinical Research Organizations (ACRO) represents companies that provide a variety of specialized services that support the development of new pharmaceuticals, biologics and medical devices. The association provides an active voice for the CRO industry globally. Through its member companies, ACRO helps improve the quality, efficiency and safety of biomedical research. ACRO member companies employ approximately 75,000 professionals worldwide and annually conduct more than 11,000 clinical trials involving nearly two million participants in 115 countries. For more information, please visit www.acrohealth.org. Twitter @acrohealth. YouTube @ACROHealthChannel.